HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saul Tzipori Selected Research

MBX-500

8/2013MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets.
9/2012MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Saul Tzipori Research Topics

Disease

30Infections
01/2022 - 02/2002
14Diarrhea
01/2021 - 10/2004
10Hemolytic-Uremic Syndrome
01/2015 - 06/2003
9Clostridium Infections
10/2016 - 08/2012
8Cryptosporidiosis
01/2022 - 12/2006
4Botulism
10/2017 - 07/2006
3Tetanus
07/2012 - 09/2010
3Type I Syndactyly
06/2011 - 06/2009
2Bacillary Dysentery (Shigellosis)
01/2022 - 03/2010
2Reinfection
01/2020 - 09/2012
2Body Weight (Weight, Body)
12/2014 - 06/2009
2Foodborne Diseases
12/2013 - 07/2006
2Acquired Immunodeficiency Syndrome (AIDS)
06/2009 - 12/2006
1Weight Loss (Weight Reduction)
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2022
1COVID-19
01/2022
1Toxoplasmosis
01/2021
1Cross Infection (Nosocomial Infection)
01/2020
1Human Influenza (Influenza)
03/2017
1Dysbiosis
10/2016
1Community-Acquired Infections
09/2016
1Starvation
01/2013
1Paralysis (Palsy)
12/2012
1Weight Gain
09/2012
1Inflammation (Inflammations)
08/2012
1Animal Diseases
07/2012
1Acute Kidney Injury (Acute Renal Failure)
06/2012
1Toxemia
02/2012
1Hemorrhage
02/2009

Drug/Important Bio-Agent (IBA)

15VaccinesIBA
01/2022 - 06/2003
9Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 02/2009
9Shiga Toxin (Shigella Toxin)IBA
01/2015 - 06/2003
7Proteins (Proteins, Gene)FDA Link
10/2017 - 07/2006
6Pharmaceutical PreparationsIBA
01/2022 - 06/2007
4trimethylaminocarboxyldihydroboran (TCDB)IBA
01/2020 - 02/2012
4AntibodiesIBA
01/2015 - 06/2003
4Shiga Toxin 2IBA
06/2012 - 08/2005
4Monoclonal AntibodiesIBA
06/2009 - 02/2002
3Immunoglobulin G (IgG)IBA
01/2022 - 11/2006
3Botulinum Toxins (Botulinum Toxin)IBA
10/2017 - 07/2006
3EnzymesIBA
10/2016 - 06/2007
3CytokinesIBA
08/2013 - 10/2005
2AntitoxinsIBA
10/2017 - 01/2012
2Azithromycin (Zithromax)FDA LinkGeneric
01/2017 - 02/2009
2nitazoxanide (NTZ)FDA Link
01/2017 - 01/2015
2Shiga Toxins (Vero Toxin)IBA
12/2013 - 10/2004
2MBX-500IBA
08/2013 - 09/2012
2AcidsIBA
01/2013 - 06/2011
2ProteomeIBA
06/2011 - 06/2009
2Interferon-gamma (Interferon, gamma)IBA
06/2009 - 08/2006
1Immune Sera (Antisera)IBA
01/2022
1L 084IBA
01/2022
1Formaldehyde (Formol)FDA Link
01/2022
1bezlotoxumabIBA
01/2020
1PiperazineIBA
01/2019
1RNA (Ribonucleic Acid)IBA
12/2018
1Biological ProductsIBA
12/2018
1PhosphoproteinsIBA
12/2018
1Phosphotransferases (Kinase)IBA
01/2018
1BKI 1369IBA
01/2018
1Fibroins (Fibroin)IBA
03/2017
1beta-Lactamases (beta-Lactamase)IBA
10/2016
1SYN-004IBA
10/2016
1Neutralizing AntibodiesIBA
09/2016
1CB-183,315IBA
07/2015
1Cysteine Proteases (Cysteine Protease)IBA
01/2015
1GlucosyltransferasesIBA
01/2015
1Tigecycline (Tygacil)FDA Link
12/2014
1DNA (Deoxyribonucleic Acid)IBA
09/2013
1Enterotoxins (Enterotoxin)IBA
08/2013
1Interleukin-12 (IL 12)IBA
08/2013
1Interleukin-8 (Interleukin 8)IBA
08/2013
1Interleukin-6 (Interleukin 6)IBA
08/2013
1Phosphates (Orthophosphate)IBA
01/2013
1CarbonIBA
01/2013
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2013
1AmmoniaIBA
01/2013
1VancomycinFDA LinkGeneric
09/2012
1Immunotoxins (Immunotoxin)IBA
08/2012
12- crotonyloxymethyl- (4R,5R,6R)- 4,5,6- trihydroxycyclohex- 2-enone (COTC)IBA
07/2012
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
05/2012
1Recombinant ProteinsIBA
01/2012
1Streptomycin (Streptomycin Sulfate)FDA Link
01/2012
1NitratesIBA
06/2011
1PropionatesIBA
06/2011
1tetanus toxin fragment CIBA
09/2010
1Shiga Toxin 1 (SLT-I)IBA
04/2010
1Virulence Factors (Pathogenicity Factors)IBA
03/2010
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2009
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2009
1Subunit VaccinesIBA
11/2009
1GelsIBA
06/2009
1Coomassie blueIBA
06/2009
1fumagillinIBA
06/2009
1Ciprofloxacin (Cipro)FDA LinkGeneric
02/2009
1ImmunosorbentsIBA
02/2009
1SubtilisinIBA
06/2007

Therapy/Procedure

11Therapeutics
01/2022 - 10/2004
1Oral Administration
06/2009
1Aftercare (After-Treatment)
02/2009